Note: Funding Information: AstraZeneca (Grant Number AZNL201900216) and Pfizer (Grant Number 54265341) partly funded the appointment of KB and thereby facilitated the implementation of the mainstream genetic testing pathway. They had no involvement in the study design, collection of data, analyses, or writing of the manuscript.